Epithelial tissues have the intrinsic capability to repair and regenerate, following irradiation or genetically induced cell death. However, how epithelial cells respond to injury and recover is not well understood. In the past few years, studies from metazoan models, such as Drosophila, forged the concept of apoptosis-induced proliferation, a process by which damaged cells entering apoptosis signal the surrounding unaffected cells to divide so as to recoup the tissue loss. 1, 2, 3 Using Drosophila developing imaginal discs as a model, several groups have demonstrated that fly wing imaginal discs submitted to g-irradiation or genetically induced cell death undergo apoptosis-induced proliferation. 4, 5 Apoptosis-induced proliferation requires Drosophila p53 and the caspase Dronc, and involves the release of mitogens such as Wingless (Wg) and Decapentaplegic (Dpp) that induce the growth of the surrounding tissues. [6] [7] [8] Apoptosis-induced proliferation has also been observed in hydra, where dying cells express Wnt that is required for cell division. 9 A recent study showed that when injected into mice, irradiated mouse embryonic fibroblasts can induce sustained growth of feeder tumour cells. 10 Specifically, this study shows that caspase 3, the executioner of apoptosis, stimulates prostaglandin E2 expression and growth of surviving tumour cells. Other studies also demonstrate that mice deficient for the p53 inhibitor, MDM2, develop intestinal hyperplasia due to the activation of the canonical Wnt and EGFR pathways. 11 Together, these results suggest that apoptosis-induced proliferation is a fundamental and conserved process by which epithelial tissues recover and regenerate after injury, and that p53 has an active role in both apoptosis and compensatory growth in mice and in Drosophila.
The p53 protein is the product of a well-known tumour suppressor gene, TP53. It is mutated in more than 50% of human cancers. Initial studies of p53 functions have highlighted its key role as a stress-induced factor, particularly in response to DNA damage. The results from decades of studies coined p53 as the 'guardian of the genome', as it induces DNA repair, cell cycle arrest or apoptosis after exposure to genotoxic stress, 12, 13 thus preventing the sequential accumulation of genetic alterations that underpins progression towards neoplasia. However, p53 is present in many lower eukaryotes, including Drosophila, where cancer is not a prevalent biological phenomenon. This paradox leads many to postulate that the tumour suppression function of p53 in vertebrates has probably evolved for some hitherto unappreciated primordial regulatory functions. [14] [15] [16] However, the exact nature of such primordial functions has remained elusive.
Until recently, TP53 was thought to be expressed as a single major transcript. This view was radically transformed in the last 15 years by the discovery of two verterbrate p53 paralogs, TP63 and TP73. These two genes encode several protein isoforms with diverse functions in neuronal development, morphogenesis, immune response and responses to specific stress. 17 Subsequent to the discovery of the DN isoforms of p63 and p73, studies have revealed that p53 express up to 12 protein isoforms generated by alternative splicing sites, codon initiation sites and internal promoter. 18, 19 In invertebrate animals, only one gene represents the TP53 gene family. It resembles TP53 more than it resembles TP63 and TP73. In Drosophila, the p53 gene structure is highly conserved compared to its mammalian homologue. Drosophila p53 (Dp53) gene structure was recently reviewed; it contains two alternative promoters and encodes three possible protein isoforms, Dp53, DDNp53 and Dp53DC. 19 Experimental evidence only confirms the presence of the fulllength Dp53 and DDNp53. Therefore, in this study, we focused on Dp53 full-length isoform corresponding to the human fulllength (TA) p53 that includes a full transactivation domain and DDNp53, a general counterpart of the N-terminal truncated human p53 forms. DDNp53 is encoded by an mRNA transcribed from an internal promoter like the N-terminally truncated human D133p53, but unlike D133p53, it contains a truncated trans-activation domain followed by a complete DNAbinding domain and an oligomerization domain such as that found in the human D40Np53. 18 These findings raise the possibility that Dp53 and DDNp53 are the respective functional homologues of the human TAp53 and D40/D133p53.
DDNp53 was the first p53 isoform identified in Drosophila and was thought to be the only p53 isoform for several years; it was therefore initially named Dp53 or Dmp53 in earlier publications. [20] [21] [22] The subsequent identification of a form of Drosophila p53 matching the mammalian full-length (TA) p53 protein has led to a reassessment of this nomenclature, with the name Dp53 to designate the fulllength protein isoform and DDNp53 for the N-terminal truncated form. Studies on fly primordial germ cells, imaginal discs and adult photoreceptor cells have highlighted the role of DDNp53 in regulating apoptosis. 21, [23] [24] [25] [26] DDNp53 induces apoptosis through the Reaper-Hid-Grim (RHG) cascade. It was proposed that DDNp53 directly activates the expression of reaper (rpr), whose protein product activates caspases by inhibiting DIAP1 (Drosophila inhibitor of apoptosis protein). 21, 22 In addition to its apoptotic function, the Dp53 locus (Dp53 and/or DDNp53) regulates several biological functions, such as cell cycle, DNA repair, aging and apoptosis-induced proliferation. 3, [27] [28] [29] [30] Here we have investigated the role of Dp53 and DDNp53 in apoptosis and apoptosis-induced proliferation. We found that both isoforms were capable of activating apoptosis, but that each induced distinct RHG family members to inhibit DIAP1. Strikingly, we observed that DDNp53 induced wg expression and enhanced proliferation in the wing imaginal disc, suggesting that DDNp53 promotes apoptosis-induced proliferation. In contrast to DDNp53, Dp53 did not induce wg expression in the absence of the endogenous p53 gene. Thus, we propose that DDNp53 is the main p53 isoform that regulates apoptosisinduced proliferation. The physiological consequences of these dual functions of p53 isoforms on apoptosis and apoptosisinduced proliferation are discussed.
Results
Dp53 and DDNp53 activate distinct RHG genes to induce apoptosis. To study the respective functions of Dp53 and DDNp53, we undertook a gain-of-function approach. We generated UAS-Dp53 and UAS-DDNp53 Drosophila transgenic lines for tissue-specific expression using the UAS/ GAL4 system. To eliminate expression level variations due to position effects, 31 we targeted individual UAS-Dp53 and UAS-DDNp53 insertions to the same chosen genomic region using the site-specific fC31 integrase system. Dp53 and DDNp53 cDNAs were expressed in the wing imaginal disc using the MS1096 driver that is specific to the wing pouch and hinge areas ( Figure 1 and Supplementary Figure 1) . 32 We observed robust production of Dp53 in wing imaginal discs using an anti-Dp53 antibody that recognizes the DNAbinding domain common to the Dp53 and DDNp53 isoforms (Figures 1a-c). Similar levels of Dp53 and DDNp53 isoforms were detected by western blot analysis ( Figure 1g ). We found that both isoforms induced caspase activation in wing imaginal discs, indicating that their expression leads to apoptosis (Figures 1d-f and Supplementary Figure S2) .
To investigate the mechanisms by which Dp53 and DDNp53 overexpression lead to apoptosis, we examined rpr and hid expression ( Figure 2 ). We used a rpr XRE -lacZ (rprZ) reporter, which carries a 2.2-kb genomic region necessary for rpr induction in response to irradiation. 25 Although Dp53 induced robust rprZ activation, DDNp53 led to only a weak rprZ response in the wing imaginal discs (Figures 2b, c and g ). To confirm this result, we tested how both Dp53 isoforms can activate p53RE-GFPnls, another rpr activity reporter, which contains a 150-bp rpr enhancer sequence embedding a consensus p53-binding site. 15 We found Dp53 induced greater levels of GFP than DDNp53 (Figures 2e and f) . Furthermore, we found that Dp53 production (en4Dp53) led to the formation of blisters in the adult wings (Supplementary Figure S3 ). Although we currently do not know what p53-related biological process is responsible for the blister formation, we found that the incidence of wing blisters was significantly reduced in an rpr mutant (Supplementary Figure  S3 and Table S1a ). Because of the pupal lethality induced by the expression of DDNp53 (en4DDNp53), we could not test whether rpr mutant reduces wing blisters in this condition. Instead, we showed that rpr mutant partially suppressed pupal lethality induced by DDNp53 (en4DDNp53), suggesting that the DDNp53-mediated phenotype involves rpr (Supplementary Table S1b ). Next, we examined hid induction by Dp53 and DDNp53 using an anti-Hid antibody. 4 However, as both Dp53 isoforms lead to rapid elimination of apoptotic cells (data not shown), Hid expression was hard to detect. To overcome this difficulty, we examined the induction of Hid expression by Dp53 isoforms with the engrailed driver in dronc-null wing discs, where the cells were kept 'undead' (Figures 2h-j) . The engrailed driver is expressed in the posterior part of the wing imaginal disc in a clearly delineated domain (Supplementary Figure S1a) . We observed much stronger Hid staining in the engrailed domain where DDNp53 was overexpressed compared with Dp53. Together, these experiments support that rpr is a primary target during Dp53-mediated apoptosis and suggest that Dp53 is responsible for
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Dp53 and DDNp53 differentially regulate apoptosisinduced proliferation. Johnston and colleagues 7 have proposed that Dp53 gene promotes the expression of mitogens, such as Wg, which is required for apoptosisinduced proliferation. However, the specific roles of the Dp53 and DDNp53 isoforms in activating Wg have not been defined. To study the roles of Dp53 and DDNp53 in apoptosis-induced proliferation, we examined wg expression and cell proliferation after Dp53 or DDNp53 proteins were produced in the developing wing tissues (Figures 3 and 4) . We first used the 'undead cell' model in which apoptosis is initiated by the expression of Dp53 isoforms but its execution is inhibited by expressing the inhibitor of caspase p35 ( Figure 3 ). We found that DDNp53 induced strong and widespread wg expression associated with hyperproliferative tissue in a deformed wing disc (Figure 3d) . In this context, we determined whether wg expression was induced in neighbouring unaffected cells, namely, in a cell-non-automous manner. We observed that DDNp53 induced wg expression both inside and outside of the engrailed domain of expression labelled with RFP (Figures 3d, d 0 and d 00 ). This result indicates that DDNp53 induces wg expression both in a cellautonomous and non-autonomous manner. In contrast to DDNp53, when ectopically expressed, Dp53 was only able to induce a moderate increase of wg that mainly resulted in a thickening of the Wg endogenous pattern of expression within the engrailed domain (Figure 3c ). Moreover, Wg expression pattern was completely normal in p53-null wing disc, indicating that endogenous p53 gene does not regulate wg expression (Figures 3a and b) . Next, we examined whether the induction of wg by Dp53 isoforms required dronc. We found that in dronc mutant wing discs, DDNp53 also induced stronger wg expression than Dp53 (Figures 3e  and f) . From these results, we conclude that the regulation of wg expression by Dp53 isoforms is dronc independent.
Next, we asked if the regulation of wg by Dp53 isoforms can be detected in 'genuine' apoptotic cells. To achieve this goal, we used the strong MS1096 wing imaginal disc driver ( Figure 4) . As in the 'undead' cell model, we observed that DDNp53 induced strong wg expression in 'genuine' apoptotic cells (Figure 4c ). The increased level of wg expression was clearly detected in the dorsal part of the wing pouch region where the MS1096 is the strongest (Supplementary Figure  S1b) . The increased wg expression was associated with tissue accumulation and folding, suggesting hyperproliferation (Figures 4c and f) . In contrast to DDNp53, Dp53 expression did not alter the overall pattern of wg expression, but resulted in a thickening of the endogenous wg expression pattern ( Figure 4b) .
Next, we used a PCNA-EmGFP reporter that monitors E2f1 activity and EdU staining for cell proliferation. 33 We observed enhanced PCNA-EmGFP labelling in the presence of DDNp53, indicating increase cell proliferation (Figure 4i ). In contrast, PCNA-EmGFP was only weakly induced by Dp53, suggesting that Dp53 induces little proliferation compared with DDNp53 (Figures 4h and i) . We also evaluated proliferation by EdU, a thymidine analogue that stains cells that have transited to S phase (Figure 4j) . Consistent with the PCNAEmGFP assay result, the EdU staining revealed that DDNp53 induces more proliferation than Dp53. Drosophila p53 gene is proposed to act in a feedback loop to self-amplify and promote apoptosis-induced proliferation.
7,34 Therefore, we wanted to examine how the endogenous p53 gene contributes to the observed overexpression phenotype. We produced DDNp53 or Dp53 in p53-null flies. 35 First, we found that elevated levels of Dp53 or DDNp53 led to robust caspase activation, indicating that each isoform can induce apoptosis in the absence of the endogenous p53 gene (Figures 5a and b) . Next, we observed that DDNp53 retained the ability to increase wg expression in the p53-null flies (Figures 5d and d  0 ) . This suggests that DDNp53 overexpression alone is sufficient to induce wg expression. In contrast, in p53-null wing discs, we observed that Dp53 expression no longer induced any thickening of wg endogenous expression pattern. Rather, we observed a reduction of wg expression, which could be attributed to apoptosis of Wg-positive cells in this area (Figure 5c 0 ). Together, these results show that DDNp53, but not Dp53, is the positive regulator of wg expression.
Discussion
The discovery of multiple p53 isoforms raises the question of their functional specificity in the spectrum of p53-mediated biological responses. In Drosophila, as the first and only p53 isoform identified in almost a decade, the truncated DDNp53 isoform was initialy presumed responsible for all p53 activities. The identification of the full-length Dp53 isoform that contains a full N-terminal transactivation domain challenged this presumption. Here, using gain-of-function studies, we examined the role of these two isoforms in apoptosis and apoptosis-induced proliferation. We found that both Dp53 isoforms activate apoptosis but preferentially activate different DIAP antagonists (Rpr or Hid) for caspase activation (Figures 1, 2 and Supplementary Figure S2) . We showed that DDNp53 promotes wg expression and cell proliferation, independently of endogenous p53, whereas Dp53 is unable to do so (Figures 3-5) . We also found Dp53 to be primarily responsible for damage-induced transcriptional activation of rpr, whereas DDNp53 is the p53 isoform dedicated to promoting apoptosis-induced proliferation.
The landmark study of Abrams and colleagues 21 showed that DDNp53 binds a DNA damage response element in the rpr regulatory region, which is responsible for the induction of apoptosis in response to irradiation. Here we showed that in wing imaginal discs, Dp53 is a stronger inducer of rpr expression than DDNp53 (Figure 2) . Moreover, we showed that DDNp53 strongly induced hid expression, whereas Dp53 was only a weak inducer. Together, these observations suggest that the transcriptional competence of DDNp53 differs from that of Dp53, and is consistent with a previous study showing that hid is transcriptionally induced by DDNp53 in eye and wing imaginal discs. 25, 28, 34 These results also suggest that some intrinsic ability to distinguish its activity for rpr and hid expressions is embedded in the N-terminus of the full length Dp53. Therefore, we propose that Dp53 is responsible for the damage-mediated activation of rpr for apoptosis, whereas DDNp53 promotes apoptosis by inducing expression of hid. The physiological consequences of this functional segregation in apoptosis regulation by p53 isoforms remain to be determined.
Previous works have shown that apoptotic cells secrete morphogens that induce proliferation of surrounding cells. 4, 36, 37 Although more clearly detected in 'undead cells', mitogen gene expression and extra proliferation have also been detected in genuine apoptotic cells. 4, 36, 38 It was proposed that the initiator caspase Dronc leads to Dp53 expression, which in turn activates mitogen gene expression, 7, 34 but the specific roles of Dp53 and DDNp53 remain to be established. Here we showed that DDNp53 is a potent inducer of wg expression both in the 'undead cell' and genuine apoptotic cell models (Figures 3-5) . Specifically, we showed that DDNp53 induced wg expression independently of dronc (Figure 3f ). This indicates that DDNp53 acts downstream of the apoptotic pathway to induce proliferation via the expression of wg. Thus, like JNK, 39 DDNp53 promotes proliferation independently of the apoptotic cascade. Further analysis will be required to determine the relationship between JNK and p53 isoforms in the induction of proliferation.
Wells et al. proposed that in the apoptosisinduced proliferation process, there is a feedback loop that activates wg expression in 'undead cells' via Dronc and Dp53. Our results are consistent with such a feedback mechanism in which Dp53 and DDNp53 induce apoptosis via rpr and hid, which in turn amplifies DDNp53 via Dronc to promote wg expression. Our results also suggest that the feedback loop not only functions in 'undead cells' but also in genuine apoptotic cells. Together, we propose that p53 isoforms act both upstream and downstream of the apoptotic pathway to promote wg expression and proliferation.
Our results show that DDNp53 is a potent inducer of wg expression in both wild-type and p53-null wing discs. In contrast, Dp53 only weakly increased wg expression in wildtype but not in p53-null flies (Figures 3-5) . Therefore, the weak induction of wg expression by Dp53 in wild-type disc is likely dependent on the endogenous p53 gene. Further investigations will be required to determine if DDNp53 is the only p53 isoform regulating wg expression or if another isoform such as Dp53DC or the one encoded by the recently annotated p53-RD transcript (Flybase) contribute as well to the regulation of wg expression.
One of the most intensely debated questions regarding Drosophila DNp53 isoforms is whether they have their own biological activity or exert a dominant negative activity on p53. [40] [41] [42] The fact that DDNp53 induced Wg expression independently of endogenous p53 gene indicates that DDNp53 does not require p53 for this function. In vertebrate studies, zebrafish D113p53 and human D133p53 do not act exclusively in a dominant-negative manner toward p53 but differentially regulate p53 target gene expression to modulate p53 function. 41, 42 Similarly, our results show that Drosophila p53 isoforms have the capacity to use distinct targets to orchestrate their biological functions; we have shown that Dp53 promotes rpr expression, whereas DDNp53 activates Hid and Wg expression in wing epithelium (Figures 2-5) . Overall, we propose that balancing apoptosis and apoptosisinduced proliferation may represent one primordial function of the TP53 gene family, and that this function requires the expression of Dp53 and DDNp53 isoforms in a tightly controlled manner. In vertebrate, this primordial functional capacity may be differently exploited by TP53, TP63 and TP73 to regulate specific aspects of death/proliferation in the equilibrium, depending upon tissues and physiological contexts.
Material and Methods UAS-Dp53 and UAS-DDNp53 transgenic lines. Dp53 and DDNp53 cDNAs were cloned (Kpn1/Xba1) into a pUAST-w þ -attB transgenic fly vector. Best Gene, Inc. (Chino Hills, CA, USA) generated transgenic lines using fC31 integrase-mediated transgenesis. Vector DNA was injected in embryos carrying attP docking sites (strain 9736 at 53B2 and strain 9750 at 65B2). W þ embryos were selected and for establishing stable transgenic fly stocks.
Fly stocks. The following transgenic and mutant fly stocks were used: MS1096-Gal4, en-Gal4, uas-lacZ and uas-RFP (Bloomington stock); uas-GFP, 43 rpr XRE -lacZ (rprZ) and dronc I29 (kind gifts from A Bergmann 25 ); p53R-GFPnls (p53 RE; a generous gift from J Abrams 15 ), rpr87, 44 deficiency (3L)H99 (Df(3L)H99, referred to as H99 45 ), PCNA-EmGFP 33 and p53-null (p53 [5A-1-4]). 35 The following genetic combinations were used to express transgenes in wing imaginal discs: (1) MS1096-Gal4,uas-GFP (MS10964GFP), (2) MS1096-Gal4;uas-Dp53 (MS10964Dp53), (3) MS1096-Gal4;uas-DDNp53 (MS10964 DDNp53), (4) enGal4/uas-Dp53 (en4Dp53), and (5) en-Gal4/uas-DDNp53 (en4DDNp53). Flies were raised under standard conditions at 25 1C.
Additional information can be found in the supplemental information.
